ConductScience.org, home

Paper42012184

Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response.

Singh S and 2 others. J Virol, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response. Papers, record 42012184. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42012184

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response.
PubMed
Journal
J Virol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-11-05
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Singh SSwarandeephttps://orcid.org/0000-0003-1186-1327
2Kumar SSanjeevhttps://orcid.org/0000-0002-8181-3999
3Luthra KKalpanahttps://orcid.org/0000-0002-7801-2867

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS VaccinesMajor topic
HIV-1Major topic
env Gene Products, Human Immunodeficiency VirusMajor topic
HIV AntibodiesMajor topic
HIV InfectionsMajor topic
Antibodies, NeutralizingMajor topic
Humans
Epitopes
Animals
Vaccine Development

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BT/PR39156/DRUG/134/91/2021Department of Biotechnology, Ministry of Science and Technology, IndiaPubMed
BT/PR30120/MED/29/1339/2018Department of Biotechnology, Ministry of Science and Technology, IndiaPubMed

Source PubMed

Download CSV of grants

References166

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121715490Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.J Virol2011https://conductscience.org/library/papers/21715490PubMed
224590074Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.Nature2014https://conductscience.org/library/papers/24590074PubMed
336206752Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens.Cell Rep Med2022https://conductscience.org/library/papers/36206752PubMed
430190230When designing vaccines, consider the starting material: the human B cell repertoire.Curr Opin Immunol2018https://conductscience.org/library/papers/30190230PubMed
526088135A New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS.J Biol Chem2015https://conductscience.org/library/papers/26088135PubMed
632075877Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.Science2020https://conductscience.org/library/papers/32075877PubMed
732675574Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies.Curr Opin HIV AIDS2020https://conductscience.org/library/papers/32675574PubMed
820577269Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design.Nat Rev Immunol2010https://conductscience.org/library/papers/20577269PubMed
933563983Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles.NPJ Vaccines2021https://conductscience.org/library/papers/33563983PubMed
1023539181Rational HIV immunogen design to target specific germline B cell receptors.Science2013https://conductscience.org/library/papers/23539181PubMed
1128847869Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo.J Exp Med2017https://conductscience.org/library/papers/28847869PubMed
1224145402Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/24145402PubMed
1321762802HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.J Mol Biol2011https://conductscience.org/library/papers/21762802PubMed
1427349805Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability.Nat Commun2016https://conductscience.org/library/papers/27349805PubMed
1526372963Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26372963PubMed
1623824824Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein.J Virol2013https://conductscience.org/library/papers/23824824PubMed
1740794027Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes.J Exp Med2025https://conductscience.org/library/papers/40794027PubMed
1840388952
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.
Lancet Microbe2025https://conductscience.org/library/papers/40388952PubMed
1940373112Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.Science2025https://conductscience.org/library/papers/40373112PubMed
2028978939Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity.Sci Rep2017https://conductscience.org/library/papers/28978939PubMed

See all 166 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42984752Immunogenicity and structure of a stabilized HIV-1 clade C Env from a pediatric elite neutralizer in complex with an autologous bnAb.Front Immunol2026https://conductscience.org/library/papers/42984752

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ERVK-20100616444PubTator's text mininghttps://conductscience.org/library/genes/100616444

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42012184

GET https://conductscience.org/api/papers/v1/42012184/references?page=2